Arix Bioscience Plc

Arix Bioscience (ARIX)

Company name:Arix Bioscience Plc
EPIC:ARIXTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BD045071
Market Segment:SSQ3Share Type:DE
WWW Address:https://arixbioscience.com/ipo-documents/Description:ORD 0.001P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 104.50 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 102.00 107.00 104.50 104.50 104.50 758
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 141.65 135.55 0.05 32.10 - 3.26 - 178.00 - 102.00

Arix Bioscience Key Figures

(at previous day's close)
Market Cap.141.65m
Shares In Issue135.55m
Prev. Close104.50
PE Ratio3.26 
Dividend Yield-%
EPS - basic32.10p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-8.16p
Return On Equity (ROE)14.12%
Operating Margin3,219.95%
PEG Factor0.00 
EPS Growth Rate29,281.82%
Dividends PS Growth Rate-%
Net Debt-81.94m
Gross Gearing3.32%
Quick Assets93.39m
Net Working Capital84.11m
Intangibles / Fixed Assets0.95%
Turnover PS0.98p
Pre-Tax Profit PS31.55p
Retained Profit PS28.14p
Cash PS67.29p
Net Cash PS60.45p
Net Tangible Asset Value PS *198.01p
Net Asset Value PS199.31p
Spread5.00 (4.67%) 

Arix Bioscience Balance Sheet

ARIX:Liabilities+EQARIX:Assets

Share Price Performance

Sample Period HighLow
1 week104.50102.00
4 weeks121.00102.00
12 weeks122.50102.00
1 year178.00102.00

Share Price Chart (5 years)

Arix Bioscience Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week103.501.000.97102.000.20103.69
4 weeks121.00-16.50-13.64102.000.11106.63
12 weeks122.50-18.00-14.69102.000.07110.98
26 weeks141.00-36.50-25.89102.000.05117.86
1 year174.00-69.50-39.94102.000.05136.51
3 years210.00-105.50-50.24102.000.06168.09
5 years210.00-105.50-50.24102.000.06168.09

Arix Bioscience Key Management Ratios

Arix Bioscience Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio3.26 
Tobin's Q Ratio 0.66 
Tobin's Q Ratio (excl. intangibles)0.67 
Dividend Yield-%
Market-to-Book Ratio0.52 
Price-to-Pre-Tax Profit PS3.31 
Price-to-Retained Profit PS3.71 
Price-to-Cash Flow PS-12.81 
Price-to-Sales PS106.67 
Price-to-Net Tangible Asset Value PS0.53 
Price-to-Cash PS1.55 
Net Working Capital PS62.05 
Price Pct to Working Capital PS1.68%
Earnings Yield30.72%
Average PE5.19 
Years in average1 
PE to PE average62.76%

Arix Bioscience Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-29.32%
Net Gearing (excl. Intangibles)-29.51%
Gross Gearing3.32%
Gross Gearing (excl. Intangibles)3.34%
Gearing Under 1 Year3.32%
Gearing Under 1 Year (excl. Intgbl)3.34%
Assets/Equity1.03 
Cash/Equity33.76 
(Liquidity Ratios)
Net Working Capital to Total Assets30.10%
Current Ratio10.06 
Quick Ratio (Acid Test)10.06 
Liquidity Ratio9.83 
Cash & Equiv/Current Assets97.67%
(Solvency Ratios)
Enterprise Value50.43m
CFO/Sales-8.33 
CFO/Attributable Profit- 
CFO/Assets-0.04 
CFO/Debt-1.19 
Total Debt/Equity Market Value0.07 
Total Debt/Sales6.99 
Total Debt/Pre-Tax Profit0.22 
Total Debt9.28m
Total Debt/Net Current Assets0.11%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
0.05050.0505

Arix Bioscience Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)15.83%
Return On Assets (ROA)17.76%
Net Profit Margin2,872.52%
Assets Turnover0.01 
Return On Equity (ROE)14.12%
Return On Investment (ROI)18.31%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio18.31%
Net Income Of Revenues2,872.52%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.01 
Fixed Assets Turnover0.01 
Current Assets Turnover0.02 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales161.74 
Debtors-to-Sales129.52%
Debt Collection Period472.74Days

Arix Bioscience Dividends

Sorry No Data Available

Arix Bioscience Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover0.64-1.86100.00%1.33100.00%m
pre tax profit-9.53--7.69-414.11%42.763,219.95%m
attributable profit-8.40--8.61-463.76%38.152,872.52%m
retained profit-8.40--8.61-463.76%38.152,872.52%m
eps - basic (p)-0.36 -0.11 32.10 
eps - diluted (p)-0.36 -0.11 29.70 
dividends per share- - - 

Arix Bioscience Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ARIX:Liabilities+EQARIX:AssetsARIX:Liabilities+EQARIX:AssetsARIX:Liabilities+EQARIX:Assets
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets0.751.43%0.520.35%0.310.11%m
intangibles intangibles2.344.47%2.061.37%1.770.63%m
fixed investments fixed investments17.1232.66%71.3347.52%183.9865.84%m
current assets - other current assets - other--%--%--%m
stocks stocks--%--%--%m
debtors debtors3.266.23%1.270.84%2.170.78%m
cash & securities cash & securities28.9355.21%74.9449.92%91.2232.64%m
TOTAL52.40100%150.12100%279.46100%m
LIABILITIES
creditors - short creditors - short6.0711.59%3.672.44%9.283.32%m
creditors - long creditors - long--%--%--%m
creditors - other creditors - other--%--%--%m
subordinated loans subordinated loans--%--%--%m
insurance funds insurance funds--%--%--%m
TOTAL6.0711.59%3.672.44%9.283.32%m
EQUITY
ord cap, reserves ord cap, reserves46.3388.41%146.4497.56%270.1796.68%m
prefs, minorities prefs, minorities--%--%--%m
TOTAL46.3388.41%146.4497.56%270.1796.68%m
OTHER
NAV Basic- - - 
NAV Diluted- - - 

Arix Bioscience Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-13.63-8.78-11.06m
Pre-Financing CF-13.63-59.03-126.50m
Retained CF28.9346.05-44.25m

Arix Bioscience Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
ARIX
Arix Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191207 11:07:25